The History of the Minneapolis Heart Institute Foundation®

In 1982, dedicated cardiovascular specialists from Minneapolis Heart Institute® at Abbott Northwestern Hospital formed the Minneapolis Heart Institute Foundation® (MHIF) to promote clinical research and education. The founding physicians sought to establish an independent nonprofit research laboratory that would allow them to investigate and develop better ways to prevent, detect and treat heart and vascular disease. They did not accept the status quo of current practice, but wanted to improve lives and advance the field of cardiology.

In establishing MHIF, the founding physicians created a world-class organization that conducts the high-quality research across the cardiovascular disease spectrum. Thirty-three years later, MHIF continues to be a highly agile and innovative cardiovascular research and education organization.

MHIF History Timeline

Navigate through the slideshow by clicking the arrows on the right and left.

Innovation and Discovery at Minneapolis Heart Institute Foundation

1982: MHIF is formed

1985: Minneapolis Heart Institute® physicians are the first to implant the Jarvik 7-70 total artificial heart.

1990: The first atherectomy in the Twin Cities is performed by a Minneapolis Heart Institute® physician.

1992: The MHIF 55 and Under Registry is the first of its kind for identifying younger patients with coronary artery disease, cerebral vascular disease and peripheral vascular disease.

1993: The MHIF Hypertrophic Cardiomyopathy Center is formed.

1994: The first coronary stent implantation in the Twin Cities is performed by a Minneapolis Heart Institute® physician.

1995: MHIF conducts research on a new surgical technique for bypass surgery, which costs less and reduces the risk of complications.

1999: The first angiogenesis trial at the MHIF begins, in an attempt to stimulate the formation of new blood vessels in areas of the heart that currently receive insufficient blood due to blockages.

2001: MHIF conducts its first gene therapy trial.

2002: The MHIF Research Internship program launches.

2003: MHIF researchers pioneer the Level One Heart Attack program to coordinate community ER departments, ER transportation professionals, and a constantly available angioplasty team.

2003: The OPTIMIST program launches the first newsletter for patients with angina and coronary artery disease blockages that cannot be fixed.

2007: MHIF becomes a member of the NIH CCTRN network of physicians, scientists, and support staff dedicated to studying stem cell therapy for treating heart disease.

2009: Hearts Beat Back®: The Heart of New Ulm Project begins.

2010: The Minneapolis Heart Institute® pioneers the collaborative Cool-It protocol, and is the first to simultaneously combine transport, emergency angioplasty and cooling.

2010: The MHIF vascular team conducts its first stem cell trial for stroke patients.

2014: MHIF is the fifth-highest enrolling site for the U.S. study of the Micra TPS study – the world’s smallest pacemaker.

2015: MHIF conducts the first-in-U.S. implant of the Tendyne mitral valve replacement device.

2016: MHIF performs its first transcarotid artery repair.